![](/img/cover-not-exists.png)
A phase 2 trial of sequential temozolomide chemotherapy followed by high-dose interleukin 2 immunotherapy for metastatic melanoma
Ahmad A. Tarhini, John M. Kirkwood, William E. Gooding, Stergios Moschos, Sanjiv S. AgarwalaVolume:
113
Year:
2008
Language:
english
Pages:
9
DOI:
10.1002/cncr.23791
File:
PDF, 169 KB
english, 2008